Skip to main content
Neurotherapeutics logoLink to Neurotherapeutics
. 2023 Feb 3;20(2):602–603. doi: 10.1007/s13311-023-01347-7

Correction to: Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy

Benjamin Ongnok 1,2,3, Thawatchai Khuanjing 2,3, Titikorn Chunchai 1,2, Patcharapong Pantiya 1,2,3, Sasiwan Kerdphoo 1,3, Busarin Arunsak 1,3, Wichwara Nawara 1,3, Thidarat Jaiwongkam 1,3, Nattayaporn Apaijai 2,3, Nipon Chattipakorn 1,2,3, Siriporn C Chattipakorn 1,2,4,
PMCID: PMC10121921  PMID: 36735181

Correction to: Neurotherapeutics https://doi.org/10.1007/s13311-021-01092-9

The authors would like to point out that the representative Western blot bands in Fig. 2E was wrongly inserted in the article as originally published. New representative Western blot image of the β-actin (Fig. 2E) has been replaced. The corrected figure is presented in the below erratum and does not alter the conclusions drawn from this work. The authors sincerely apologize for this error.

Fig. 2.

Fig. 2

The effects of donepezil on neuroinflammation and oxidative stress in rats with doxorubicin-induced chemobrain. A TNF-α mRNA expression. B IL-6 mRNA expression. C Brain MDA levels. D GPx4 protein expression. E SOD2 protein expression. n = 4–6/group; * p < 0.05 vs. Control; † p < 0.05 vs. Dox (one-way ANOVA followed by an LSD post hoc test). Dox, doxorubicin; DPZ, donepezil. GPx4, glutathione peroxidase 4; IL-6, interleukin-6; SOD2, superoxide dismutase 2; TNF-α, tumor necrosis factor-α

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES